GranuFlo and Naturalyte heart attack form dialysis medication lawyers are filing lawsuits for cardiac injury and death from GranuFlo and Naturalyte.

There was a class 1 recall of GranuFlo last year due to cardiac injury during or just after dialysis treatment. NaturaLyte is a liquid acid concentrate and GranuFlo is a dry acid concentrate. Both products contain sodium acetate that converts to bicarbonate at higher then expected rates leading to immediate cardiac arrest in many dialysis patients and cardiac injury bin others.
At year s end in 2012,a Motion to Consolidate the cases into multidistrict litigation (MDL) for all federal lawsuit was filed. A request has been filed with the U.S. Judicial Panel on Multidistrict Litigation asking that all Naturalyte and GranuFlo lawsuits filed in U.S. District Courts throughout the country be consolidated for pretrial proceedings in the District of Massachusetts.
Early in 2013, Fresenius said in court papers that it agreed that consolidation of the NaturaLyte and Granuflo litigation was appropriate and supported the transfer of the cases to the District of Massachusetts
On January 3, several Plaintiffs with pending lawsuits have objected to centralizing the cases in Massachusetts, indicating that the litigation should be consolidated in the southeast, because of the number of cases filed in that region. Their choices are the Southern District of Mississippi and the Northern District of Alabama have been requested. Many Florida retired seniors are dialysis patents and have been injured or killed sue to a cardiac episode from GranuFlo or Naturalyte.